Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

BATS BZX Real-Time Price
As of 3:31pm ET
 -0.045 / -1.16%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Adaptimmune Therapeutics PLC have a median target of 8.00, with a high estimate of 17.00 and a low estimate of 4.00. The median estimate represents a +108.60% increase from the last price of 3.84.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Adaptimmune Therapeutics PLC. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -405.00%
Growthannually -578.33%


Growthquarterly 218.65%
Growthannually 115.87%
Key to the earnings and sales forecast charts.